{"id":59845,"date":"2026-03-18T14:00:41","date_gmt":"2026-03-18T06:00:41","guid":{"rendered":"https:\/\/flcube.com\/?p=59845"},"modified":"2026-03-18T14:00:41","modified_gmt":"2026-03-18T06:00:41","slug":"kintor-pharma-partners-with-chicmax-to-accelerate-kt-939-commercialization-active-cosmetic-ingredient-targets-whitening-market","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=59845","title":{"rendered":"Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market"},"content":{"rendered":"\n<p><strong>Kintor Pharmaceutical Limited<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/9939:HKG\">HKG: 9939<\/a>) has entered into a <strong>strategic partnership<\/strong> with <strong>Shanghai Shangmei Cosmetics Co., Ltd (Chicmax, <a href=\"https:\/\/www.google.com\/finance\/quote\/2145:HKG\">HKG: 2145<\/a>)<\/strong> to advance the <strong>rapid commercialization of KT\u2011939<\/strong>, Kintor&#8217;s <strong>active cosmetic ingredient<\/strong> for <strong>whitening and anti\u2011freckle applications<\/strong>, leveraging Chicmax&#8217;s regulatory expertise and market presence in China&#8217;s functional cosmetics sector.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-overview\">Transaction Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Deal Type<\/strong><\/td><td>Strategic partnership with exclusivity provisions<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>KT\u2011939 \u2013 active cosmetic ingredient (whitening\/anti\u2011freckle)<\/td><\/tr><tr><td><strong>Licensor\/Developer<\/strong><\/td><td>Kintor Pharmaceutical Limited (HKG: 9939)<\/td><\/tr><tr><td><strong>Commercialization Partner<\/strong><\/td><td>Shanghai Shangmei Cosmetics Co., Ltd (Chicmax, 2145.HK)<\/td><\/tr><tr><td><strong>Territory<\/strong><\/td><td>China (initial focus)<\/td><\/tr><tr><td><strong>Strategic Goal<\/strong><\/td><td>Position KT\u2011939 as influential domestic whitening agent<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-partnership-scope-amp-strategic-pillars\">Partnership Scope &amp; Strategic Pillars<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Collaboration:<\/strong> Joint filing of <strong>KT\u2011939 as new cosmetic ingredient<\/strong> with China NMPA cosmetics regulatory pathway<\/li>\n\n\n\n<li><strong>Product Registration:<\/strong> Registration of <strong>cosmetic products containing KT\u2011939 as core ingredient<\/strong><\/li>\n\n\n\n<li><strong>Exclusivity Terms:<\/strong> Partnership includes exclusivity provisions (territory\/segment scope not disclosed)<\/li>\n\n\n\n<li><strong>R&amp;D Integration:<\/strong><\/li>\n\n\n\n<li>Joint research and development efforts<\/li>\n\n\n\n<li>Customization of functional ingredients for specific applications<\/li>\n\n\n\n<li>Co\u2011development of formulation technologies<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-profile-amp-market-positioning\">Product Profile &amp; Market Positioning<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Ingredient:<\/strong> <strong>KT\u2011939<\/strong> \u2013 Kintor\u2011developed active cosmetic ingredient<\/li>\n\n\n\n<li><strong>Primary Claims:<\/strong> <strong>Whitening<\/strong> and <strong>anti\u2011freckle<\/strong> efficacy<\/li>\n\n\n\n<li><strong>Development Origin:<\/strong> Pharmaceutical\u2011grade R&amp;D capabilities applied to cosmetic active (Kintor&#8217;s androgen receptor and dermatology expertise leveraged)<\/li>\n\n\n\n<li><strong>Market Positioning:<\/strong> <strong>Domestic alternative<\/strong> to established whitening agents (kojic acid, arbutin, vitamin C derivatives); targets &#8220;influential domestic whitening agent&#8221; status in China&#8217;s <strong>RMB45+ billion<\/strong> skin\u2011brightening market<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale-amp-synergies\">Strategic Rationale &amp; Synergies<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Dimension<\/th><th>Kintor Pharma<\/th><th>Chicmax (Shangmei)<\/th><\/tr><\/thead><tbody><tr><td><strong>Core Competency<\/strong><\/td><td>Pharmaceutical R&amp;D; active ingredient discovery; regulatory science<\/td><td>Cosmetic brand management; consumer product commercialization; China beauty market distribution<\/td><\/tr><tr><td><strong>Contribution to Partnership<\/strong><\/td><td>KT\u2011939 asset; clinical\u2011grade efficacy data; regulatory filing expertise<\/td><td>Regulatory navigation for cosmetic ingredients; formulation development; market access and consumer insights<\/td><\/tr><tr><td><strong>Strategic Benefit<\/strong><\/td><td>Revenue diversification beyond therapeutic pipeline; validation of pharma\u2011cosmetic convergence<\/td><td>Access to novel, clinically\u2011validated active ingredient; differentiation in competitive whitening segment<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-outlook\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>China Whitening Cosmetics Market:<\/strong> Skin\u2011brightening products represent <strong>RMB45\u201160 billion<\/strong> annual segment (15\u201120% of total skincare market); regulatory tightening on established whitening agents (hydroquinone restrictions, arbutin concentration limits) creates demand for next\u2011generation alternatives with demonstrated safety\/efficacy profiles.<\/li>\n\n\n\n<li><strong>Pharma\u2011Cosmetic Convergence Trend:<\/strong> Kintor&#8217;s KT\u2011939 partnership follows industry pattern of biotech firms leveraging pharmaceutical R&amp;D rigor for &#8220;cosmeceutical&#8221; applications (e.g., peptide\u2011based actives, growth factor derivatives); regulatory advantage of clinical\u2011grade safety data vs. traditional cosmetic ingredient development.<\/li>\n\n\n\n<li><strong>KT\u2011939 Competitive Positioning:<\/strong> Positioned as <strong>domestic innovation<\/strong> in whitening category historically dominated by Japanese (Shiseido, Kose) and Western (L&#8217;Or\u00e9al, Est\u00e9e Lauder) heritage brands; &#8220;China\u2011developed&#8221; positioning aligns with consumer nationalism trends and regulatory preference for domestic innovation.<\/li>\n\n\n\n<li><strong>Revenue Timeline:<\/strong> New cosmetic ingredient registration in China typically requires <strong>12\u201118 months<\/strong>; first commercial products containing KT\u2011939 expected <strong>2027\u20112028<\/strong> assuming regulatory approval; royalty\/milestone structure likely includes upfront payment, regulatory milestones, and sales\u2011based royalties.<\/li>\n\n\n\n<li><strong>Kintor Pipeline Diversification:<\/strong> Partnership demonstrates Kintor&#8217;s strategy to monetize platform technologies beyond therapeutic indications; KT\u2011939 success validates broader dermatology asset commercialization potential (KT\u2011474, other pipeline candidates).<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding regulatory timelines, commercialization expectations, and market positioning for KT\u2011939. Actual results may differ due to risks including regulatory approval delays, competitive dynamics in whitening ingredients, and consumer adoption rates.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/2026031701471_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2026031701471_c.\"><\/object><a id=\"wp-block-file--media-5670f801-5b1d-4e9a-8ac9-96d3c06a260a\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/2026031701471_c.pdf\">2026031701471_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/2026031701471_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-5670f801-5b1d-4e9a-8ac9-96d3c06a260a\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Kintor Pharmaceutical Limited (HKG: 9939) has entered into a strategic partnership with Shanghai Shangmei Cosmetics&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4644,547,100,4645],"class_list":["post-59845","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-hkg-2145","tag-kintor-pharmaceutical","tag-medical-aesthetics","tag-shangmei-cosmetics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Kintor Pharmaceutical Limited (HKG: 9939) has entered into a strategic partnership with Shanghai Shangmei Cosmetics Co., Ltd (Chicmax, HKG: 2145) to advance the rapid commercialization of KT\u2011939, Kintor&#039;s active cosmetic ingredient for whitening and anti\u2011freckle applications, leveraging Chicmax&#039;s regulatory expertise and market presence in China&#039;s functional cosmetics sector.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=59845\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market\" \/>\n<meta property=\"og:description\" content=\"Kintor Pharmaceutical Limited (HKG: 9939) has entered into a strategic partnership with Shanghai Shangmei Cosmetics Co., Ltd (Chicmax, HKG: 2145) to advance the rapid commercialization of KT\u2011939, Kintor&#039;s active cosmetic ingredient for whitening and anti\u2011freckle applications, leveraging Chicmax&#039;s regulatory expertise and market presence in China&#039;s functional cosmetics sector.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=59845\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-18T06:00:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59845#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59845\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market\",\"datePublished\":\"2026-03-18T06:00:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59845\"},\"wordCount\":551,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"HKG: 2145\",\"Kintor Pharmaceutical\",\"Medical aesthetics\",\"Shangmei Cosmetics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=59845#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59845\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=59845\",\"name\":\"Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-03-18T06:00:41+00:00\",\"description\":\"Kintor Pharmaceutical Limited (HKG: 9939) has entered into a strategic partnership with Shanghai Shangmei Cosmetics Co., Ltd (Chicmax, HKG: 2145) to advance the rapid commercialization of KT\u2011939, Kintor's active cosmetic ingredient for whitening and anti\u2011freckle applications, leveraging Chicmax's regulatory expertise and market presence in China's functional cosmetics sector.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59845#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=59845\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=59845#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market - Insight, China&#039;s Pharmaceutical Industry","description":"Kintor Pharmaceutical Limited (HKG: 9939) has entered into a strategic partnership with Shanghai Shangmei Cosmetics Co., Ltd (Chicmax, HKG: 2145) to advance the rapid commercialization of KT\u2011939, Kintor's active cosmetic ingredient for whitening and anti\u2011freckle applications, leveraging Chicmax's regulatory expertise and market presence in China's functional cosmetics sector.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=59845","og_locale":"en_US","og_type":"article","og_title":"Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market","og_description":"Kintor Pharmaceutical Limited (HKG: 9939) has entered into a strategic partnership with Shanghai Shangmei Cosmetics Co., Ltd (Chicmax, HKG: 2145) to advance the rapid commercialization of KT\u2011939, Kintor's active cosmetic ingredient for whitening and anti\u2011freckle applications, leveraging Chicmax's regulatory expertise and market presence in China's functional cosmetics sector.","og_url":"https:\/\/flcube.com\/?p=59845","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-03-18T06:00:41+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=59845#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=59845"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market","datePublished":"2026-03-18T06:00:41+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=59845"},"wordCount":551,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["HKG: 2145","Kintor Pharmaceutical","Medical aesthetics","Shangmei Cosmetics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=59845#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=59845","url":"https:\/\/flcube.com\/?p=59845","name":"Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-03-18T06:00:41+00:00","description":"Kintor Pharmaceutical Limited (HKG: 9939) has entered into a strategic partnership with Shanghai Shangmei Cosmetics Co., Ltd (Chicmax, HKG: 2145) to advance the rapid commercialization of KT\u2011939, Kintor's active cosmetic ingredient for whitening and anti\u2011freckle applications, leveraging Chicmax's regulatory expertise and market presence in China's functional cosmetics sector.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=59845#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=59845"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=59845#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Kintor Pharma Partners with Chicmax to Accelerate KT\u2011939 Commercialization \u2013 Active Cosmetic Ingredient Targets Whitening Market"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/59845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=59845"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/59845\/revisions"}],"predecessor-version":[{"id":59849,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/59845\/revisions\/59849"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=59845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=59845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=59845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}